Application

16219681 · ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE

Filed 2018-12-13 · Granted · Patent 10307417 (2019-06-04) The official file ↗The patent and its PDF ↗ · Art unit 1618 · Examiner Robert S Cabral Typical · CPC A61K 9/284 · Wyeth, LLC · McCarter & English, LLP / Salix Pharmaceuticals

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

3.1 mo

to disposition 5.7 mo

Statutes raised

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.